Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort.

Journal of neuroimmunology - 1 Dec 2004

Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O A, Grove J, Liu Y, Abdul-Majid K-B, Gartner S, Sacktor N

Abstract excerpt

There are discrepant findings regarding the risk of HIV-associated dementia (HAD) relating to apolipoprotein E4, suggesting other factors may modulate risk. Furthermore, evidence suggests a changing phenotype of HAD in the era of highly active antiretroviral therapy (HAART), prompting a need to determine if new disease markers have emerged. In this analysis, APOE genotype was determined for 182 participants...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Risk
Share to Aging
Share to AIDS Dementia Complex

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiretroviral Therapy, Highly Active

Share to Apolipoprotein E4

Share to Apolipoproteins E

Share to Hawaii

Share to HIV Infections

Source

Identifiers

PMID: 15579298
DOI: 10.1016/j.jneuroim.2004.08.029

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort.PMID 15579298Read ↗

Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.Semantic proximity Read ↗

Association of Phenotypic Aging Marker with comorbidities, frailty and inflammatory markers in people living with HIVSemantic proximity Read ↗

Genomic Factors and Therapeutic Approaches in HIV-Associated Neurocognitive Disorders: A Comprehensive ReviewSemantic proximity Read ↗

Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review.Semantic proximity Read ↗

HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy.Semantic proximity Read ↗

Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy.Semantic proximity Read ↗

Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severitySemantic proximity Read ↗

No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death.Semantic proximity Read ↗

Association of apolipoprotein E epsilon 4 and cognitive impairment in adults living with human immunodeficiency virus: a meta-analysis.Semantic proximity Read ↗

Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults.Semantic proximity Read ↗

An exploratory pilot study on the involvement of APOE, HFE, C9ORF72 variants and comorbidities in neurocognitive and physical performance in a group of HIV-infected people.Semantic proximity Read ↗

Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.